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Hsp70s are the most well conserved protein family known, and yet little of their activity
within the cell is understood. Hsc70 is a constitutively expressed member of the Hsp70
family found in the cytosol of almost all eukaryotic cells. Hsc70 has many functions within
the cell, including assisting with the folding of nascent peptides, targeting proteins for
degradation, and remodelling protein complexes. All Hsp70s consist of two highly
conserved domains, the nucleotide binding domain and the substrate binding domain,
joined by a flexible linker region. The juxtaposition of the two domains is dependent on the
nucleotide bound by the nucleotide binding domain. These conformations have been
studied in vitro, but not in vivo, so it is not known exactly how conformational change
contributes to functions within the cell. Many previous studies of Hsp70s have relied on the
bacterial form, DnaK. In this study, Hsc70 constructs were produced based on previously
made DnaK versions. Using these constructs, the nucleotide dependent conformational
shifts of Hsp70s were probed by Förster Resonance Energy Transfer (FRET). To do this,
fluorescent dyes were attached to each domain of the protein. This allowed direct
comparisons to be made between Hsc70 and DnaK. In this study we showed that
tris(2-carboxyethyl)phosphine behaved anomalously on gel filtration, compromising the
labelling protocol. This was improved by a change of reductant and gel filtration conditions.
Of the four sites tested for labelling, one potential site, Q520, was found to be totally
refactory to labelling. One of the aims of this study was to find an Hsc70 construct that
would produce a strong FRET signal, which could then be used in future single molecule in
vivo studies. The variant E318C/T427C/C574S/C603S gave the strongest signal of the four
variants tested. Analysis of this variant also showed that Hsc70 and DnaK conformations
are not the same, with ADP bound DnaK spending less time with the linker region exposed
to solvent than ADP bound Hsc70 does.
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Chapter 1
Introduction
1.1 Hsp70 molecular chaperones
1.1.1 Hsc70
The Hsp70 family of chaperone proteins is found in all forms of life and is the most highly
conserved protein family, with the various eukaryotic forms showing > 60% similarity to
each other and 45 - 50% similarity to prokaryotic DnaK (Gupta, 1998). Hsp70s are found
throughout the cell, with isoforms present in the cytosol, the nucleus, the endoplasmic
reticulum, mitochondria and plastids (Parsell and Lindquist, 1993). Combined, these makes
up approximately 1% of the total protein in the cell under normal conditions, and 2% in
stressed cells (Zuiderweg et al., 2013). They have been shown to be involved in the de novo
folding of nascent peptides, targeting proteins for degradation, the transport of unfolded
proteins across membranes, as well as remodelling of protein complexes and uncoating of
clathrin coated vesicles (Kampinga and Craig, 2010; Hartl et al., 2011).
Hsc70 is a constitutively expressed 73 kDa member of the eukaryotic Hsp70s. Hsc70
suppresses apoptosis and has been shown to be over-expressed in many tumours, such as
those in colon cancer and breast carcinoma. As such, Hsp70s are promising potential
targets for anti-cancer drugs (Evans et al., 2010; Li et al., 2015; Sherman and Gabai, 2015).
Conversely under-expression of Hsc70 has been implicated in many neurodegenerative
disorders, such as Parkinson’s and Alzheimer’s diseases (Liu et al., 2012).
1
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1.1.2 Structure
All Hsp70s consist of a nucleotide binding domain (NBD), also refered to as the ATPase
domain, and a substrate binding domain (SBD), joined by a short linker. There is also an
inherently disordered C-terminal tail. In all cytosolic Hsp70s, this C-terminal tail ends with
a EEVD motif that is essential for both ATPase activity and J-domain co-chaperone
interaction (Freeman et al., 1995).
The NBD has a low level of constitutive ATPase activity. It is made up of four
sub-domains, which enclose the bound nucleotide (Flaherty et al., 1990). The NBD’s
ATPase activity is synergistically enhanced by binding of substrate by the SBD, and the
J-domain co-chaperones. The J-chaperones present substrates, such as auxilin, clathrin or
unfolded peptides, to the Hsp70s. The exact number of J-domain chaperones that interact
with Hsc70 is unknown, but includes at least four of the Hsp40s. Nucleotide exchange
factors (NEFs) facilitate the release of ADP, allowing ATP to bind (Karzai and McMacken,
1996; Laufen et al., 1999). Hsc70 interacts with a large number of NEFs, including the
BAG family, Hip, Hop, CHIP and HSPBP1 (Liu et al., 2012).
Ths SBD consists of a substrate binding pocket within a region of β -sheets, and an
α-helical lid. When ADP is bound in the NBD, the SBD and NBD are only in contact with
each other via the linker, which is exposed to the solvent. The lid of the SBD is closed.
When ATP is bound, the lid of the SBD is open and makes multiple contacts with the NBD,
and the linker is sequestered (Figure 1.1).
The seperate domains of Hsc70 have been crystallised, with and without various
substrates bound (DeLuca-Flaherty et al., 1988; Flaherty et al., 1990; Zhu et al., 1996). The
flexable nature of the linker region, as well as that of the C-terminus, make crystallisation of
the full-length molecule difficult, particularly in the ADP bound state. Two methods that
have been used to overcome this are nuclear magnetic resonance (NMR) (Swain et al.,
2006; Bertelsen et al., 2009) and small-angle X-ray scattering (SAXS) (Wilbanks et al.,
1995; Shi et al., 1996). Interestingly, these last two studies, which focused on bacterial
DnaK and human Hsc70, respectively, drew differing conclusions as to the native
oligomeric state of the molecules in their ADP bound states, with Shi et al., finding that
DnaK formed multimeric oligomers, and Wilbanks et al., finding that Hsc70 dimerised.
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Many studies use E. coli DnaK as a model for human Hsp70s; however, there are some
advantages to using Hsc70 for studies in live cells. DnaK is a simple model with few
co-chaperone partners. Eukaryotic Hsp70s on the other hand have many co-chaperones
with varying affinities and specificities (Yu et al., 2015). For in vitro experiments, it is
therefore more convenient to study DnaK, which only requires DnaJ and GrpE to function
effectively. Reconstitution of eukaryotic Hsp70 systems is more complex however, since
Hsp70s, J-domain co-chaperones and NEFs are all found naturally in all cells, the
eukaryotic system is attractive for investigating interactions within living cells.
Figure 1.1: Ribbon diagram of nucleotide dependent Hsp70 conformational changes.The left
panel shows a composite NMR and crystallography structure of the predicted conformation of the
Hsp70 DnaK when ADP is bound in the nucleotide binding domain (Bertelsen et al., 2009). The
nucleotide dinding domain is shown in magenta, the linker in cyan, and the substrate binding domain
in blue. The right panel shows crystal structure of DnaK with ATP bound in the NBD (Kityk et al.,
2012). Colour scheme is the same as in the left panel, with ATP shown as sticks.
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1.1.3 Substrate binding and release cycle
The conformations shown in Figure 1.1 show significant rearrangement of the various
domains and sub-domains. A number of methods have been used to investigate the action of
Hsp70s. The model Hsp70, E. coli DnaK, has a single endogenous tryptophan residue at
position 102. The indole ring of tryptophan can be made to fluoresce by excitation at
290 nm. This produces an emission maximum of which the magnitude and wavelength are
both dependent on the local environment of the tryptophan. In the absence of ATP, the
maximum is at 338 nm. When ATP is added, this maximum is shifted to 334 nm and the
fluorescence yield is decreased. This quenching is not observed when the SBD is removed,
indicating that ATP binding causes the NBD to come into close contact with the SBD
(Buchberger et al., 1995). Hsc70 contains more than one tryptophan, limiting the use of this
technique in this study.
NMR has also shown that the Transverse relaxation optimized spectroscopy (TROSY)
spectra of isolated NBD and SBD domains overlay the spectrum of full length Hsp70 in the
presence of ADP, but not in the presence of ATP (Swain et al., 2006). This result also points
to the two domains acting independently when ADP is bound, and only interacting with one
another in the presence of ATP.
During the folding of substrate peptides, the Hsc70/peptide complex goes through a
number of ATP-dependent binding and release cycles (Figure 1.2). With ATP bound, the lid
of the SBD is held away from the β domain of the SBD, exposing the substrate binding
pocket. In this conformation, affinity for substrate peptides is low (Takeda and McKay,
1996) and ATP hydrolysis is slow, in the order of one ATP per Hsp70 per 20 to 30 min
(McCarty et al., 1995; Mayer et al., 2000). A J-domain co-chaperone delivers an unfolded
peptide to the Hsp70, which binds to exposed hydrophobic resides of the sustrate. Binding
of the substrate and the J-chaperone induces nucleotide hydrolysis. This leads to a large
conformational shift, in which the lid of the SBD clamps down over the substrate, and the
NBD and SBD move apart, exposing the linker (Palleros et al., 1993). By tying the closing
of the SBD to the delivery of substrate by the J-chaperone, this system ensures that the lid
only closes when substrate is present.
Hsp70s interact with a wide variety of substrates, some of which will not fit entirely into
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the subtrate binding domain. Schlecht et al. (2011) used electron paramagnetic resonance
spectroscopy to show that the lid region of the SBD took on multiple conformations to
accommodate different substrates.
Following ATP hydrolysis, a nucleotide exchange factor can interact with the NBD,
leading to the release of the bound nucleotide. This enables ATP to bind and causes the
Hsp70 to return to the ATP-bound conformation, opening the SBD and releasing the
substrate. If the peptide does not fold upon release, multiple iterations may be required
(Szabo et al., 1994).
Exactly how the hydrolysis of ATP by the NBD is translated into the remodelling of the
SBD is as yet unknown. The extreme nature of the conformational shift also leaves room
for the possibility of transient intermediate states that disappear too quickly to be captured
in ensemble measurements. A recent study by Banerjee et al. (2016) has used single
molecule Förster Resonance Energy Transfer (FRET) to look for some of the transient
states adopted by the lid region and found that the lid adopts several different conformations
that enable Hsp70s to accommodate differing substrates.
1.2 Förster resonance energy transfer
FRET is the non-radiative transfer of energy from a donor to an acceptor fluorophore over
distances of approximately 10 to 100 Å. For this to occur, the donor fluorophore must have
an emission spectrum that overlaps the absorption spectrum of the acceptor. The efficiency








Where E is the energy transfer efficiency, R = the distance between the two fluorophores,
and R0 = the Förster distance at which E = 0.5 for the fluorophore pair used (Selvin, 2000).
This means that the efficiency of energy transfer is inversely dependent on the sixth
power of the distance between the fluorophores. Because of this, small changes in the
distance between the fluorophores which cause them to pass from one side of the Förster
distance to the other give rise to large changes in FRET efficiency as shown in Figure 1.3.
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Figure 1.2: Nucleotide dependent peptide binding and release cycle. Hsc70/DnaK represented
by magenta, cyan and blue symbol (see Figure 1.1). J-Domain Co-chaperone represented by red
symbol. Nucleotide exchange factor in brown. Substrate peptide in yellow.
In ensemble FRET experiments, a sample is excited at a wavelength that is absorbed by
the donor fluorophore. A scan of the resulting emission spectrum can then be taken to
indicate the excitation of the acceptor fluorophore by non-radiative emission from the
donor. This gives an indication of average distance between them. This technique has been
used to study the dynamics of the mitochondrial form of human Hsp70, mtHsp70. Mapa
et al. (2010) used FRET from Atto532 and Atto647N dyes to show that, not only the
hydrolysis of ATP to ADP, but also the presence of substrate was required to completely
undock the NBD and SBD domains of mtHsp70 during protein binding and release. They
also showed that the ADP bound state of mtHsp70 was more heterogeneous than that of
DnaK making it more similar to that of the Hsp70s of higher eukaryotes. By attaching pairs
of Alexa Fluor® dyes to different parts of the SBD lid region, Banerjee et al. (2016) were
able to use FRET to show that in DnaK the structure of the lid formed at least two distinct
conformations in the ADP bound state.
Single molecule FRET involves observing the emission from individual protein
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Figure 1.3: FRET efficiency as a function of distance between fluorophores. Graph showing the
output of Equation 1.1 where R0 = 60 Å. When the donor fluorophore (green) is excited while the
fluorophores (depicted as stars) are in close proximity, emission from the acceptor fluorophore (red)
is increased (left cartoon). When the donor fluorophore is excited while the fluorophores are further
apart, acceptor emission is decreased (right cartoon).
molecules in real time. This enables short-lived intermediates to be observed. It also means
that unlabelled and mislabelled protein molecules can be recognised and ignored. In
addition with a fluorophore on each domain of Hsc70, the rate of transition between
conformations can be observed. FRET reporters would allow the study of Hsc70 activity
within a cell. To date, with the exception of Mapa et al. (2010), most FRET studies of
Hsp70s have concentrated on the lid region of the SBD. We hope to be able to shed more
light on the overall conformational shifts taking place during substrate binding and release.
One potential approach to FRET in live cells would be to express the protein with dyes
attached to the ends via gene fusion. However, due to the conserved nature of the termini of
Hsc70, other locations for the attachment of fluorophores were required. In this work,
Alexa Fluor® dyes were chosen. Alexa dyes provide both a high quantum yeild and high
extinction coefficient both of which are important in single-molecule FRET . These dyes
are attached to the protein via conjugation between a maleimide moiety attached to the dye
and a thiol of a cysteine residue on the protein. These cysteines must be accessable to the
dye molecule and in a reduced state as ionisation speeds up the reaction.
Previous studies in the Wilbanks lab had produced variants of DnaK which had the only
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endogenous cysteine mutated to a serine, and then cysteines added at various points of
interest (Walsh, 2012). For initial studies of DnaK, a single cysteine was added. This was
then used to conjugate an IAEDANS molecule to the protein. Since IAEDANS has an
excitation maximum at 336 nm, this allowed FRET via excitation of the endogenous
tryptophan. This approach was limited by the relatively low signal strength from the
IAEDANS, which was insufficient for future single molecule studies, as well as by the
inability to look at other positions within the NBD.
In order to probe other combinations of locations, variants of DnaK were produced with
one cysteine within each of the domains. In the study presented here, Hsc70 variants with
cysteine in the equivalent positions were made in order to both compare the FRET
efficiency of Hsc70 and DnaK, and to find useful constructs for future in vivo studies of
Hsc70.
1.3 Limited Proteolysis
While many studies attempt to alter the activity of an enzyme by mutating residues of
interest, in this study the aim was to perturb the function of the enzymes as little as possible.
In Hsp70s, the ability of the enzyme to undergo a large conformational shift and release of
substrate in response to allosteric binding of ATP is essential to chaperone function. It is
this shift that is being probed during FRET experiments, so any mutations that affect the
protein’s ability to undergo this shift would be undesirable. Limited proteolysis allows
monitoring of the ability of a variant to undergo conformational change by probing the
proportion of time the protein spends in each conformation.
In this technique a protease is added to the protein sample and incubated for a limited
period of time. The sample is then treated with trichloroacetic acid to precipitate and stop
the reaction. The resulting pellet is then resuspended and the cleaved products analysed by
SDS-PAGE (Cleveland et al., 1977).
When Hsp70s are in the closed ATP bound state, only the termini of the protein are
exposed to the protease. This gives rise to a truncated form of protein with a molecular
weight of approximately 60 kDa. In the ADP bound state, the linker region is exposed,
allowing it to be cleaved and leading to the separation of the nucleotide binding and
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substrate binding domains, giving rise to bands at approximately 44 and 23 kDa,
respectively.
A major advantage of this method of monitoring protein function is that it is doesn’t
require any expensive equipment or reagents, unlike NMR or SAXS, which need heavy
isotopes or a synchrotron respectively. It is also much quicker than either of these methods,
both of which require a great deal of data analysis.
1.4 Aims of this study
The overall goal of this study was to establish a useful FRET reporter for use in future
smFRET studies of Hsc70. Three aims were established to achieve this:
A) Design, express and purify Hsc70 variants based on those previously used to study
DnaK.
B) Optimise a fluoresent labelling protocol to doubly label variants with Alexa Fluor®
dyes.






DnaK and Hsc70 plasmids used in this work are shown in Table 2.1. The FRET
experiments performed in this study rely on fluorescent dyes attached to the sample proteins
via the reaction of a maleimide moity to the thiol of an exposed cyteine residue on the
protein. To facilitate this, constructs were obtained which had the naturally occuring
cysteines at reside 15 in DnaK, or residues 574 and 603 in Hsc70 mutated to serine. From
these plasmids, constucts were made which contained two cysteine residues, one each
within the NBD and PBD domains of the protein.
Previous work on DnaK in the Wilbanks lab had found positions N254 and K321 on the
NBD, and E430 and R517 on the SBD to be both solvent exposed and not well conserved,
and thus unlikely to be essential to the function of the protein (see Figure 2.1).
Sequence alignment and homology modelling were used to determine homologous
positions on Hsc70. On the NBD, these were determined to be E255 and E318. On the
SBD, Q520 was chosen as analagous to R517. Residue S432 was determined to be the
equivalent to E430; however, Mapa et al. (2010) suggested that position T427 might
produce better FRET signal.
The DnaK C15S plasmid was created previously in the Wilbanks lab. The DnaK
C15S/K321C/R517C plasmid, hereafter referred to as KR was created in this study by site
10
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Figure 2.1: Positions of introduced cysteine moieties on DnaK. The left panel shows a ribbon
diagram of DnaK in an ADP bound state (Bertelsen et al., 2009). The right panel shows a ribbon
diagram of DnaK with ATP bound (from crystal structure in Kityk et al. (2012)). Nucleotide binding
domain is shown in magenta, linker is shown in cyan, and substrate binding domain is shown in blue.
Mutated residues are shown in green, with their side chain shown as sticks. Residue numbers are
indicated, with DnaK above and Hsc70 below. Images created in Pymol.
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Table 2.1: Protein variants used in this study
Hsp70 Homologue Variant Abbreviation Sourcea





C15S/K321C/R517C KR This study
Hsc70 C574S/C603S ∆2C J.Renshawc
E255C/T427C/C574S/C603S 2T GeneScript
E255C/Q520C/C574S/C603S 2Q This study
E318C/T427C/C574S/C603S 3T This study
E318C/Q520C/C574S/C603S 3Q Genescript
a Source of expression plasmid
b Previous work by the author of this study
c Previous member of the Wilbanks lab
directed mutagenesis of the DnaK C15S/R517C plasmid created by a previous member of
the Wilbanks lab, Samuel Walsh, using primers that he had designed. All other DnaK
plasmids were obtained from Samuel Walsh (Walsh, 2012).
Two Hsc70 plasmids were purchased from Genescript. The remaining two were created
from the two purchased (see Sections 2.2.2 and 2.2.3).
2.1.2 Reagents
Table 2.2: Reagents used in this study
Reagent (Full name of reagent) Suppliera
Acetone VWR
Acrylamde (30% acrylamide/bis solution 37:5:1) Bio-Rad
ADP (Adenosine diphosphate) Sigma
AF488 (Alexa Fluor 488®) Sigma
AF594 (Alexa Fluor 594®) Sigma
Ampicillin Goldbio
APS (Ammonium persulphate) Bio-Rad
Continued on next page
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Table 2.2 – continued from previous page
Reagent (Full name of reagent) Suppliera
Argon (Zero grade argon) BOC
ATP (Adenosine triphosphate) Sigma
βME (β -mercaptoethanol) Sigma
Bromophenol blue VWR
CaCl2 (Calcium Chloride) VWR
Charcoal (Activated charcoal) Riedel-deHaën
Chloramphenicol Goldbio
Coomassie blue (Coomassie blue G250) VWR
DMSO (Dimethyl sulfoxide) Molecular Probes
DTT (Dithiothreitol) Roche
EDTA (Ethylenediaminetetraacetic acid) VWR
E.Z.N.A® plasmid extraction kit VWR
Glycerol Merck
Glycine Lab Supply
GSSG (Oxidised glutathione) Sigma
HCl (Hydrochloric acid) VWR
HEPES (4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid) Lab Supply
IPTG (Isopropyl β -D-1-thiogalactopyraoside) Lab Supply
Kanamycin Goldbio
KCl (Potassium chloride) Lab Supply
KH2PO4 (Potassium dihydrogen phosphate) VWR
MgCl2 (Magnesium chloride) VWR
Molecular weight marker (Broad range molecular weight marker) Bio-Rad
MQ (18.2 MΩ·cm water) Merck
Na2HPO4 (Disodium hydrogen phosphate) VWR
NaCl ( Sodium chloride) Merck
Continued on next page
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Table 2.2 – continued from previous page
Reagent (Full name of reagent) Suppliera
PMSF (Phenylmethylsulfonyl fluoride) Sigma
Proteinase K Sigma
SAP (Shrimp alkaline phosphatase) Roche
SDS (Sodium dodecyl sulfate) Merck
T4 ligase Roche
TCA (Trichloroacetic acid) VWR
TCEP (tris(2-carboxyethyl)phosphine) ThermoFisher
TEMED (Tetramethylethylenediamine) VWR
Tris (Trisaminomethane) Lab Supply







DEAE (Diethylaminoethanol fast flow Sepharose)b GE
ATP (Adenosine Triphosphate agarose C-8 linkage, 9 atom spacer)b Sigma
Superdex 200 (HiLoad 26/600 Superdex)c GE
Hi-Prep 26/60 desalting columnc GE
Miscellaneous equipment Suppliera
Chromatography columns Ace Glass
Vivaspin® 30,000 MWCO concentrators Merck
Nap-5 desalting columns GE
PD-10 desalting columns GE
Continued on next page
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Table 2.2 – continued from previous page
Reagent (Full name of reagent) Suppliera
a For addresses of suppliers see page 15
b Column poured from hydrated resin
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2.2 Methods
2.2.1 Construct design
The constructs for expression of Hsc70 used in this work were based on DnaK constructs
previously used by members of the Wilbanks lab for FRET analysis. In order to measure
the effect of different nucleotide binding states on the conformation of Hsc70/DnaK, a
fluorescent dye molecule is attached at a defined location in each of the two domains of the
enzyme. To facilitate this, cysteine residues were introduced at suitable locations within
each domain, and surface exposed endogenous cysteine resides mutated to serines. The
dyes were then attached to these introduced cysteines via a maleimide linker.
DnaK sequence from Bertelsen et al. (2009) and Hsc70 sequence from DeLuca-Flaherty
and McKay (1990) were aligned using ClustalW, and Hsc70 residues corresponding to
those showing promise in the DnaK variants were selected. Chosen residues were checked
against the structure 2KHO Bertelsen et al. (2009) to ensure that they were surface-exposed
(Figure 2.2).
2.2.2 Construction of Hsc70 E255C/Q520C/C574S/C603S plasmid
The Hsc70 E255C/T427C/C574S/C603S and E318C/Q520C/C574S/C603S plasmids were
purchased from GeneScript. Hereafter these variants are referred to as 2T and 3Q
respectively, since the C574S and C603S substitutions were present in all of the Hsc70
constructs used.
Since these two plasmids contained the same sequences, other than the mutations
indicated, it was possible to create the other two desired plasmids by using the same
restriction endonucleases to cut each plasmid on either side of both the mutation to be
removed and the desired mutation site. The resulting fragments were then digested with an
additional restriction enzyme, so that only those fragments containing the desired mutations
were left intact. These fragments were then ligated. The E255C/Q520C/C574S/C603S
plasmid (hereafter 2Q) was created as follows.
There is a HindIII restriction site between the codons for residue 318 and 427, as well as
an EcoRI site downstream of the codon for residue 520. Cutting either plasmid at these sites
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Figure 2.2: Alignment of amino acid sequences of E. coli DnaK (lower sequence) vs. bovine
Hsc70 (upper sequence). Sequences aligned using ClustalW2. Positions to be changed to cysteines
highlighted in green.
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therefore created a fragment containing codons 255 and 318, and a second smaller fragment
containing codons 427 and 520. To facilitate screening, unwanted fragments were digested
again to reduce the chances of them religating. These reactions were then combined and
ligated to create the 2Q plasmid.
Even though they are both active in the same reaction buffer, EcoRI and HindIII digests
were carried out sequentially as recommended by the manufacturer. Two microlitres of
approximately 100 ng.µL-1 of each plasmid were added to separate 200 µL PCR tubes. One
microlitre of Roche 10 × buffer B, 0.25 µL of 10 U.µL-1 EcoRI and 6 µL of MQ was then
added to each tube. The solutions were incubated at 37 °C for 2 h. The solutions were then
incubated at 65 °C for 15 min to heat inactivate the enzyme. HindIII (4 units) was added to
each tube, and the solutions were again incubated at 37 °C for 2 h before a second heat
inactivation step. Then 1 µL of EcoRV was added to the tube containing the 3Q plasmid to
reduce the chance of the E318C containing fragment being reincorporated in the final
ligation as there is an EcoRV restriction site within it. This tube was incubated at 37 °C for
2 h. Similarly, SmaI was used to cut the small unwanted fragment containing the T427C
site in the 2T plasmid. However, this required a change of buffer, Therefore, the tube
containing the 2T plasmid was subjected to sodium acetate/ ethanol precipitation as
described in Bollag et al. (1996). Briefly as follows.
Two microlitres of 3 M sodium acetate was added. Thirty microlitres of ice-cold 96%
ethanol was added. The solution was incubated on ice for 5 minutes. The solution was
centrifuged at 13000 rcf, at 4 °C for 15 min. The supernatant was discarded. The pellet was
washed with 80% ethanol. The pellet was then resuspended in 8 µL of MQ. One microlitre
of Roche 10 × buffer A and 1 µL of 10 U.µL-1 SmaI were added. The sample was incubated
at 25 °C for 2 h, then at 60 °C for 15 min to inactivate the enzyme. Three microlitres of
10 × SAP buffer, 16 µL of MQ and 1 µL of 1 U.µL-1 shrimp alkaline phosphatase (SAP)
were added. The sample was incubated at 37 °C for 1 h, then 65 °C for 15 min to heat
inactivate the enzyme.
The sample containing the 3Q plasmid was then subjected to sodium acetate
precipitation, as described above. The pellet was resuspended in 5 µL of 10 × T4 DNA
ligase buffer and 14 µL of MQ. The contents of the 2 tubes were combined, and 1 µL of T4
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DNA ligase added. The sample was incubated overnight at 4 °C.
The sample was then used to transform competent DH5α cells. These were plated out
on LB agar plates containing 100 mg.mL-1 ampicillin. Plasmid was purified using E.Z.N.A.
plasmid mini kit I columns. Sequencing of these plasmids by Genetic Analysis Service,
University of Otago Ltd (GAS) using T7 primers showed a sample with the correct 2Q
combination, but where the sequence between the 2 EcoRI restriction sites was missing.
This sample was digested with EcoRI and ScaI as described above. A sample of the 2T
plasmid was digested with EcoRI and treated with SAP, as described above, to produce a
replacement segment that would be incapable of ligating back into its parental plasmid.
These samples were mixed and ligated with T4 DNA ligase.
This sample was again used to transform DH5α cells, colonies selected, and plasmids
extracted. This time sequencing showed the desired plasmid.
2.2.3 Construction of Hsc70 E318C/T427C/C574S/C603S plasmid
To produce the Hsc70 E318C/T427C/C574S/C603S plasmid (hereafter 3T), both the 2T
and 3Q plasmids were digested with HindIII and EcoRV. The 2T digest was then SAP
treated. The 3Q sample was digested with ScaI-HF. There is a ScaI restriction site within
the ampicillin resistance cassette, so this would make it less likely for the fragment
containing the AmpR and the Q520C site to be present in the final ligation product. The
resulting samples were combined and ligated. This sample was again used to transform
DH5α cells and plasmids extracted. Sequencing by GAS using T7 primers showed the
desired mutations were present.
2.2.4 SDS-PAGE
SDS-PAGE used throughout this project was carried out using 12% acrylamide
Laemmli-style gels based on methods described in Bollag et al. (1996), using Hoefer gel
casting and electrophoresis equipment. Briefly, gels were made in a 4-gel multi-caster by
mixing the resolving gel (see above) in a 50 mL centrifuge tube and pouring 26 mL into the
multi-caster. Then 600 µL of isopropanol was pipetted onto the top of each gel. After
polymerization, isopropanol was poured off and the top of the gels rinsed with MQ.
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Sections of paper towel were used to blot the top of the gels dry. Stacking gel was pipetted
onto the resolving gels.
4 × Resolving buffer
1.5 M Tris-HCl (pH 8.8)
0.4% SDS
4 × Stacking buffer
0.5 M Tris-HCl (pH 6.8)
0.4% SDS
Resolving gel
10 mL acrylamide (30% acrylamide/Bis solution, 2.6% cross-linker)
6.25 mL 4 × resolving buffer
8.5 mL MQ
250 µL 10% w/v ammonium persulfate
30 µL N,N,N′,N′-tetramethylethane-1,2-diamine
Stacking gel
3 mL acrylamide (30% acrylamide/Bis solution, 2.6% cross-linker)
4.5 mL 4 × stacking buffer
10.5 mL MQ
100 µL 10% w/v ammonium persulfate
30 µL N,N,N′,N′-tetramethylethane-1,2-diamine
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5 × High glycerol sample buffer
60 mM Tris-HCl (pH 6.8)
2% w/v SDS
0.1% w/v bromophenol Blue
32.5% v/v glycerol
5% v/v β -mercapto-ethanol




Gels were run in 1 × SDS-PAGE running buffer. It was previously noted that some
samples were difficult to load due to the samples floating out of the wells. To counter this,
the composition of the 5 × sample loading buffer was altered to increase the glycerol
content. 5 × High glycerol sample buffer was added to each sample in a 1 to 4 ratio.
Bio-Rad broad-range marker was used as per manufacturer’s instructions for all molecular
weight markers.
All gels were run in 1 × SDS-PAGE running buffer at 100 V until the dye-front reached
the base of the stacking gel, then at 200 V until the dye-front reached the base of the
resolving gel.
2.2.5 Transformation
All bacteria used were made competent for transformation by incubation in calcium
chloride (Dagert and Ehrlich, 1979) and stored at -80 °C. All DnaK variants were expressed
in BB1553 cells (Bukau and Walker, 1989). All Hsc70 variants were expressed in
BB1553(DE3) cells (Renshaw, 2015). All plasmid amplification was carried out in DH5α
cells. In all cases, 1 µL of solution containing the appropriate plasmid was added to 50 µL
of cells. The cells were incubated on ice for 30 min. They were then heat shocked for 45 s
at either, 37 °C for BB1553 or BB1553(DE3), or 42 °C for DH5α . They were then returned
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to the ice for 2 min. Eight hundred microlitres of LB, containing 30 mg.mL-1
chloramphenicol when used for BB1553 or BB1553(DE3), was added. The culture was
then incubated at 28 °C on a shaker table for 1 h in the case of BB1553 or BB1553(DE3), or
37 °C for 45 min for DH5α , before being centrifuged at 13000 rcf for 2 min. Eight hundred
microlitres of the supernatant was discarded and the cells resuspended in the remaining
liquid. The resuspended cells were then spread on agar plates containing 100 mg.mL-1
ampicillin. BB1553 or BB1553(DE3) plates also contained 30 mg.mL-1 chloramphenicol.
The plates were incubated at either 28 °C for 20 h for BB1553 or BB1553(DE3), or 37 °C
for 16 h for DH5α .
2.2.6 Purification
2.2.6.1 Expression
Single colonies of transformed BB1553 or BB1553(DE3) were used to inoculate 50 mL LB
containing 30 mg.mL-1 chloramphenicol and 100 mg.mL-1 ampicillin in baffled 250 mL
conical flasks. Cultures were incubated overnight on a 200 rpm shaker table at 28 °C . Four
millilitres of this culture was used to inoculate 400 mL LB containing 30 mg.mL-1
chloramphenicol and 100 mg.mL-1 ampicillin in baffled 2 L conical flasks. Cultures were
incubated on a shaker table at 28 °C. When cultures reached an OD600 of approximately
0.5, IPTG was added to a final concentration of 400 µM. Cultures were harvested after
appropriately 20 h by centrifugation at 12000 rcf for 25 min at 4 °C. Resulting cell pellets
were stored at -20 °C until use.
To test expression levels, 1 mL of culture was spun down before the addition of IPTG,
and just prior to harvesting. To account for the difference in the number of cells present,
each sample was resuspended in a volume equal to OD600 × 100 µL of high glycerol sample
buffer. Samples were then incubated at 95 °C for 15 min. Equal volumes, either 4 or 8 µL,
of each were analysed by SDS-PAGE.
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2.2.6.2 Cell lysis
Lysis buffer
20 mM Tris-HCl (pH 6.9)
50 mM NaCl
100 µL EDTA
100 µL PMSF from 100 µL stock in ethanol
All variants were purified by FPLC using a protocol previously established and
optimised by members of the Wilbanks lab (Braun et al., 1996; Moir, 2014). Briefly, cells
were resuspended in sufficient lysis buffer to allow transfer to a 40 mL Dounce
homogeniser. Cultures were then homogenised, before being transferred to a chilled metal
beaker in an ice-water slurry. OD600 readings were then taken of 1 in 40 dilutions the cell
suspensions and more lysis buffer added to bring these readings below 1.0. Cells were lysed
by sonication using a Heat Systems Ultrasonics Sonifier cell disruptor, the probe of which
had been chilled in ice for 30 min prior to use. The instrument was set at power output level
9, pulsed with a 40% duty cycle for 6 min. The lysate was swirled gently then sonicated on
the same settings for a further 6 min. OD600 readings were then taken of 1 in 40 dilutions
the cell lysates. Lysates were clarified by centrifugation at 20000 rcf at 4 °C for 25 min,
then being passed sequentially through 0.45 and 0.2 µm syringe filters.
2.2.6.3 DEAE chromatography
DEAE low salt buffer
20 mM Tris-HCl (pH 6.9)
50 mM NaCl
100 µL EDTA
100 µL PMSF from 100 µL stock in ethanol (added just before use)
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DEAE high salt buffer
20 mM Tris-HCl (pH 6.9)
1.0 M NaCl
100 µL EDTA
100 µL PMSF from 100 µL stock in ethanol (added just before use)
Dialysis buffer
20 mM Tris-HCl (pH 6.9)
150 mM KCl
4 mM EDTA
All chromatography was carried out at room temperature. Clarified lysates were loaded
onto a 160 mL fast-flow DEAE anion exchange column equilibrated in DEAE low salt
buffer at a flow rate of 3 mL per min. The column was then washed with 100 mL of DEAE
low salt buffer. Protein was eluted using a 480 mL gradient from 0% to 60% DEAE high
salt buffer. This was followed by a 150 mL gradient from 60% to 100% DEAE high salt
buffer. The column was then washed with 30 mL of DEAE high salt buffer, followed by
250 mL of DEAE low salt buffer. 20 mL fractions were collected and analysed by
SDS-PAGE.
Fractions to be pooled for further analysis were selected either based on the presence of
a prominent band at 70 kDa in the case of DnaK variants, or based on the knowledge that
Hsc70 eluted at a conductivity of between 22 to 28 mS.cm-1 (18% to 22% high salt buffer).
2.2.6.4 ATP-agarose chromatography
ATP-agarose low salt buffer
20 mM Tris-HCl (pH 6.9)
25 mM KCl
3 mM MgCl2
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ATP-agarose high salt buffer








In order to remove bound nucleotide from the sample to allow binding to ATP-agarose,
fractions containing Hsc70/DnaK were pooled and dialysed overnight at 4 °C in 1 L
dialysis buffer containing a small section of dialysis tubing filled with activated charcoal
(hereafter refered to as a charcoal slug). The charcoal slug absorbs nucleotide released by
the enzyme when the co-ordinating magnesium ion is chelated by the EDTA in the dialysis
buffer. Dialysis buffer was changed after 16 hours.
Samples from dialysis were recovered into 100 mL measuring cylinders. The enzyme
requires a magnesium ion to co-ordinate the binding of nucleotide, therefore MgCl2 was
added to give a final concentration of 10 mM. This concentration being sufficient to
overcome the 3 mM EDTA in the dialysis buffer. Samples were incubated at RT for 30 min.
Samples were centrifuged at 12000 rcf at 4 °C for 25 min, then passed sequentially through
0.45 and 0.2 micron filters. Samples were then loaded onto a 12 mL or 6 mL (see
Discussion) ATP-agarose column equilibrated in ATP low salt buffer. The column was
washed with 1 column volume of ATP high salt buffer followed by 1 column volume of
ATP low salt buffer. Samples were eluted with 3.5 column volumes of ATP elution buffer
followed by 5 column volumes of ATP low salt buffer. The entire flow-through was
collected as 1 fraction, then 1 mL fractions were collected thereafter. Fractions were
analysed by SDS-PAGE and fractions containing Hsc70/DnaK, visible as a prominent band
at appromimately 70 kDa, were pooled and concentrated to less than 2 mL.
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2.2.6.5 Gel filtration chromatography
Gel filtration buffer
20 mM HEPES (pH 7.6)
100 mM KCl
5 mM MgCl2
Hsp70 in the ADP bound state is known to dimerise (Palleros et al. (1993)). In order to
avoid this, ATP (pH 7) was added to samples to an approximate final concentration of
1 mM, and allowed to incubate at 4 °C for 20 min. Samples were loaded onto a HiLoad
26/60 prep grade Superdex 200 column run at 3 mL per minute and 2.5 mL fractions were
collected from 80 mL onward. Fractions were analysed by SDS-PAGE and fractions of
interest pooled. Samples were concentrated and aliquoted into appropriately labeled 1.7 mL
microcentrifuge tubes. These tubes were then frozen in liquid nitrogen and stored at -80 °C.
2.2.6.6 Confirmation by Mass Spectroscopy
The identities of the Hsc70 proteins purified were confirmed by Mass Spectroscopy.
Samples of the purfied proteins were run on an SDS-PAGE gel, bands of the appropriate
mass were excised and sent to the Centre for Protein Research facility at the University of
Otago for analysis. The samples were subjected to tryptic digestion and analysis by
Quadropole/Orbitrap Mass spectroscopy.
2.2.7 Alexa Fluor® labelling
2.2.7.1 Handling of reagent
Alexa Fluor® (AF) 488 and 594 were dissolved in dry DMSO to 1 mM concentrations and
aliquoted at 50 µL in a nitrogen filled glove box with an oxygen level of less than 2 ppm.
Aliquots were sealed within the glove box and the tops of the tubes wrapped with
Parafilm®. They were stored at -20 °C in an argon filled light-proof container containing
silica desiccant. All work with AF dyes was carried out under zero-grade argon.
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2.2.7.2 Labelling reaction
Fluorescent labelling buffer










The initial labelling protocol was developed by David Rogawski, a previous member of
the Wilbanks lab (Rogawski, 2010). Briefly as follows:
The Alexa Fluor® dyes used in this study were purchased conjugated to a flexable linker
with a maleimide moiety on the other end. This maleimide reacts with the reduced thiol of
the target cysteine residues. In order to prevent oxidation of the thiol, or the maleimide,
prior to this reaction, the labelling reaction was carried out under low oxygen conditions.
Fluorescent labelling (FL) buffer was degassed under partial vacuum and then sparged with
zero-grade argon at 3 L per min for 1 h to drive off any remaining desolved oxygen.
Aliquots of < 1 mg of protein desalted into FL buffer using NAP-5 columns.
Concentration was measured using a Nano-drop spectrophotometer. Aliquots of 100 nMol
were transfered to 1 mL screw-capped tubes and reductant added. The volume was then
brought up to 500 µL with FL buffer.
TCEP was used to reduce the thiols. TCEP was chosen over DTT because, according to
the manufacturer it did not need to be removed before maleimide conjugation
(ThermoFisher website 20/June/2016). This was found not to be the case (see section 3.2.1).
Reductant was removed by desalting with NAP-5 columns into amber 4 mL
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screw-capped HPLC vials with septum lids. Small magnetic stir bars were added, and the
volume in the tubes brought up to 2.5 mL with degassed FL buffer to avoid dye aggregation
due to high concentration. Amounts of AF488 equal to the amount of protein present were
injected into each sample. Samples were incubated at room temperature on a stir plate in
the dark for 30 min. The 5 × molar excess of AF594 was injected. Samples were incubated
for a further 2 h.
To remove unbound excess dye, samples were first passed through a PD-10 desalting
column, then a HiPrep 26/10 desalting column.
2.2.8 Ensemble assay of FRET
After removal of nucleotide by dialysis, samples for ensemble FRET were recovered into
15 mL centrifuge tubes. MgCl2 was added to a final concentration of 10 mM. A portion of
the dialysis buffer was also retained and brought to 10 mM MgCl2 for use as buffer blank.
Samples were incubated at RT for 30 min to allow uptake of the magnesium. Samples were
then passed through 0.2 micron syringe filters. Ten microlitres of MQ, 100 mM neutralised
ATP or 100 mM neutralised ADP were added to separate 1.7 mL microcentrifuge tubes.
Nine hundred and ninety microlitres of protein stock was added to each tube and mixed by
inversion. Samples were incubated for 5 min, and then transferred to a fluorescence cuvette
and scanned using a Cary Varian® fluorescence spectrophotometer.
Samples were excited at 490 nm, and emission was recorded from 500 to 700 nm, with
5 nm excitation and emission slit widths. The PMT detector voltage was set at 600 V. It was
observed that at this excitation wavelength AF594 is also directly excited. Therefore, a
sample labelled only with AF594 was analysed under each of the conditions used.
To determine the relative amount of AF594 present, each sample was excited at 590 nm,
at 600 volts with 5 nm slit widths, and emission measured from 600 nm to 700 nm.
Scans of buffer samples, with the addition of the appropriate nucleotide, were also taken
at each wavelength. All sample spectra had the appropriate background buffer spectra
subtracted before further analysis.
Excitation scans were corrected for the direct excitation of the AF594 in each sample
using Equation 2.1.
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Where Sx is the spectrum for the variant x corrected for direct excitation of the acceptor
fluorophore. Dx is the uncorrected spectrum for the variant x when excited at 485 nm. D594
is the spectrum for the 594only variant when excited at 485 nm. R x
594
is the ratio of bound














Where i is a wavelength between 600 and 700 nm inclusive. xi is the emission signal at
the wavelength i from the variant x when excited at 590 nm. 594i is the emission signal at
the wavelength i when the 594only control was excited at 590 nm.
2.2.9 Single molecule assay of FRET
The methods used in this work were adapted from those used by a previous lab member,
Samuel Walsh (Walsh, 2012).
2.2.9.1 Cover-slip preparation







Cover-slips were aminosilanized by incubating them for 5 min in commercial
Vectabond® reagent diluted 1 in 50 with acetone. Cover-slips were then rinsed with MQ.
Cover-slips were biotinylated by pipetting 35 µL of biotin solution onto the centre of a
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cover-slip and placing a second cover-slip over the top of it. The pairs of cover-slips were
then placed in a clean empty pipette tip box, which still contained an insert and a layer of
MQ in the bottom of the box to ensure a humid environment. The box was then incubated
in the dark for 24 h. Biotinylation of the cover-slip was carried out within 1 week of Total
internal reflection microscopy (TIRF) experiments to prevent degradation of surface, as
delays had been observed to increase the background signal.
2.2.9.2 Biotinylation of samples
The Sulfo-NHS biotin reagent reacts with lysine residues. Given the large number of lysine
residues on the protein, it was deemed important not to have an excess of biotin, as this
would risk protein being unable to change conformation because it was bound at multiple
sites. Sulfo-NHS-biotin was made up to 10 mM concentration in biotin solution, and added
to the samples such that the protein concentration was 5 times that of the biotin. Samples
were incubated on ice for 3 h, then unreacted biotin was removed using a HiPrep 26/10
desalting column. Two millimolar Trolox reagent was dissolved in SM buffer and mixed by
rotation at 4 °C for 72 h.
2.2.9.3 TIRF microscopy
TIRF microscopy was carried out using an Olympus Hybrid TIRF microscope at the
Department of Physiology, University of Otago. A Duel View video coupler (dichroic
mirrior 585 nm sharp), fitted with emission filters 525 nm and 600-650 nm for AF488 and
AF594, respectively, was used to split the output into 2 channels so that the donor and
acceptor fluorophores could be measured independently. Cover-slips were secured in
microscope cover-slip holder biotinylated side up. Two milligrams per millilitre
NeutrAvidin dissolved in SM buffer was applied to the cover-slip. This was incubated at RT
for 5 min, then rinsed off with SM buffer. Biotinylated protein sample was diluted in SM
buffer to approximately 2 nM. Two hundred microlitres of diluted protein solution was
applied to the cover-slip and incubated for 10 min at RT. The cover-slip was rinsed with SM
buffer. Two hundred microlitres of 1 mM Trolox was applied and the holder was mounted
in the microscope stage. The microscope was focused under visual light conditions, so that
several frames could be recorded to be used to align the images from the beam splitter.
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The microscope was then set to direct excitation with the 488 nm laser using a GFP
filter with laser intensity of 10%. Objective magnification was 1 × with 100 × objective lens
and 100 ms exposure. Recordings were begun as soon as the microscope could be focused
on a new spot on the cover-slip as fluorophores began to burnout immediately. Energy from
the laser created slight changes in the temperature of the area of the cover-slip being
illuminated, resulting in very slight expansion of the cover-slip. Consequently, it was
necessary to constantly change the focus setting in order to maintain focus. Recordings
continued until not enough spots were left to use as a reference to maintain focus.
Multiple recordings were made before the Trolox solution was removed by pipetting.
Two hundred microlitres of 1 mM ATP in Trolox solution was then added. The cover-slip
was allowed to incubate for 5 min before new recordings were made.
2.2.10 Limited proteolysis
5 × limited proteolysis reaction buffer





In the ATP-bound configuration of Hsp70s, the linker region is sequestered, while in the
ADP-bound configuration it is exposed to solvent. This is probed in a limited proteolysis
assay. Here, fungal proteinase K is used to cleave the exposed linker sequence. By limiting
the amount of time the reaction is allowed to proceed, it is possible to compare the relative
amount of time spent in each conformation in different nucleotide binding states.
This technique for examining conformational change in Hsp70 was developed by
Buchberger et al. (1994). Samples previously used for ensemble-FRET were thawed on ice,
along with the remaining nucleotide free portion, and 800 µL of each of the three tubes
previously used for FRET were aliquoted into separate microcentrifuge tubes. Seven
hundred and ninety two microlitres of the nucleotide free portion was aliquoted into a
fourth tube and 48 µL of MQ added. This formed the no Proteinase K control. Two hundred
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microlitres of 5 × limited proteolysis reaction buffer was added to each tube. Forty
microlitres of 1 mg.mL-1 Proteinase K was added to the first 3 tubes of each sample. Tubes
were mixed by brief vortexing. Samples were incubated at RT for 5 min. Fifty microlitres
of 100% w/v TCA was added to each tube. Samples were vortexed briefly, then placed in a
pre-chilled metal block at -20 °C for 1 h. Samples were centrifuged at 13000 rcf for 10 min.
The supernatants were discarded. Pellets were washed with 100 µL of ice-cold acetone.
Samples were centrifuged at 13000 rcf for 10 min. Supernatants were discarded. Sample
tubes were placed in a 65 °C heatblock with lids open for 5 min to remove any remaining
acetone. Pellets were resuspended in 20 µL of 5 × SDS-PAGE high glycerol sample buffer.
Samples were then analysed by SDS-PAGE.
Chapter 3
Results
3.1 Expression and purification
3.1.1 Expression
The DnaK variants were created from a plasmid originally created by Montgomery
(Montgomery et al., 1999). This plasmid contains a tac promoter upstream of the coding
region, as well as a gene for lacIq, allowing repression as well as induction by IPTG. This
plasmid also provides ampicillin resistance. This plasmid had had the C15S mutation added
previously by the author of this study.
The Hsc70 variants were expressed from plasmids as described in methods (2.2). These
plasmids conferred ampicillin resistance and a T7 promotor, but did not contain lacIq.
To avoid contamination with endogenous DnaK, samples were produced in BB1553
cells, which lack DnaK (Bukau and Walker, 1989). The Hsc70 construct required a T7
polymerase, which BB1553 cells do not contain, so Hsc70 variants were produced in
BB1553(DE3) cells (Renshaw, 2015).
In general, DnaK variants showed higher levels of expression than Hsc70 variants (See
Figure 3.1).
3.1.2 Cell lysis
After sonication an OD600 measurement of 1 in 40 dilutions of each of the samples was
taken and compared to the measurement taken prior to lysis. All samples showed a decrease
34
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Figure 3.1: SDS-PAGE gels demonstrating relative expression levels of DnaK vs. Hsc70.
Experimental lanes contain an equal number of E. coli cells containing either the Hsc70 ∆2C or
DnaK C15S plasmid, as indicated (See Section 2.2.5). Overnight induction, or not, with IPTG is
indicated above each lane. Red arrows indicate Hsc70/DnaK. Marker lanes contain molecular weight
markers (~500 ng per band); molecular masses are indicated at left.
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Figure 3.2: Chromatograph showing DEAE purification of DnaK variant KE. Blue trace indi-
cates absorbance at 280 nm. Red trace indicates conductivity. Fractions analysed by SDS-PAGE are
indicated in green. Fractions pooled for further purification are in dark green.
in OD600 of > 95%, except for 3T. In this case, the sample was not adequately chilled,
resulting in the sample producing a large amount of foam during sonication. This lead to an
OD600 reading of 0.15 post sonification, approximately 5 times that of the other samples.
3.1.3 DEAE chromatography
DnaK/Hsc70 purification used 3 chromatography steps. The first is a DEAE anion
exchange step. Previous results showed that Hsc70/DnaK eluted at approximately
25 mS.cm-1. Fractions around this conductivity showing absorbance at 280 nm were
analysed by SDS-PAGE. Typically, the three most promising 20 mL fractions were pooled
and dialysed to remove bound nucleotide (See Figures 3.2 and 3.3).
3.1.4 ATP-agarose chromatography
The key step in the purification was ATP-agarose chromatography. The EDTA present in
the dialysis buffer chelates the magnesium ion that the enzyme requires to co-ordinate the
binding of nucleotide. A dialysis bag of activated charcoal was added to the dialysis. The
charcoal absorbs the nucleotide from solution, thus driving the equilibrium in favour of
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Figure 3.3: SDS-PAGE gel analysis of DEAE chromatography. Marker lane contains molecular
weight markers (~500 ng per band); molecular masses are indicated at left. Lane 2 contains 0.01%
of the clarified cell lysate which was loaded onto the DEAE column. Other lanes contain 0.05% of
the fractions indicated by the numbers at the top. Green numbers indicate fractions pooled for futher
purification.
release of more nucleotide. The high affinity of DnaK/Hsc70 for nucleotide ensures tight
binding to the column until the sample is eluted with excess ATP (Figure 3.4).
DnaK variants showed high levels of purification, with very few contaminants visible
even when gels were highly over-loaded (Figure 3.5). Unbound DnaK is present in the
flow-though. This was done to saturate the available binding sites and reduce
contamination. Due to lower levels of expression, Hsc70 variants failed to saturate the
available binding sites on the column, leading to more contamination. The most prominent
contaminant band (~45 kDa) was found by mass-spectroscopy to be an endogenous
tryptophanase of E. coli.
3.1.5 Gel filtration chromatography
The final step in the purification protocol was gel filtration chromatography. This allowed
not only the removal of any remaining contaminants which had made it through the
previous steps, but also the removal of oligomers. (Figure 3.6). Previously run standards
CHAPTER 3. RESULTS 38
Figure 3.4: Chromatograph showing ATP-agarose purification of DnaK variant KE. Blue trace
indicates absorbance at 280 nm. Shaded bars show buffer steps. Fractions analysed by SDS-PAGE
are indicated in green. Fractions pooled for further purification are in dark green.
Figure 3.5: SDS-PAGE gel analysis of ATP-agarose chromatography. Marker lanes contain
molecular weight markers (~500 ng per band); molecular masses are indicated at left. Lane 2 contains
0.005% of the sample which was loaded onto the ATP-agarose column. Lane 3 contains 0.4% of the
60th mL of flow-through. Other lanes contain 0.4% of the fractions indicated by the numbers at the
top.
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Figure 3.6: Chromatograph showing gel filtration purification of DnaK variant KE. Blue trace
indicates absorbance at 280 nm. Fractions analysed by SDS-PAGE and pooled for further analysis
are indicated in dark green.
Figure 3.7: SDS-PAGE gel analysis of gel filtration chromatography. Marker lanes contain
molecular weight markers (~500 ng per band); molecular masses are indicated at left. Experimental
lanes contain 0.16% of the fractions indicated by the numbers at the top.
showed that monomeric and dimeric DnaK/Hsc70 were expected to elute at approximately
210 and 175 mL, respectively. ATP was added to samples prior to loading onto the column
to drive the protein toward the monomeric state by causing it to release any bound substrate,
which due to the purity of the sample, was most likely another DnaK/Hsc70 molecule. The
ATP was evident on the chromatograph as a peak at around 300 mL. Analysis of the
relevant fractions by SDS-PAGE showed a high level of purity as no contaminant bands
were evident, even when the gel was overloaded (Figure 3.7).
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3.1.6 Purification summary
To show overall purity of the samples after gel filtration, aliquots of the samples after
concentration were analysed by SDS-PAGE (Figure 3.8). All Hsc70 variants showed more
degradation products than the DnaK variants, but no other substantial contaminants were
visible.
Figure 3.8: SDS-PAGE showing purified variants. 2T, 2Q, 3T, 3Q show 0.1% of total yield. NE
shows 0.25% of total yield. NR, KE, KR show 0.01% of total yield. Marker lanes contain molecular
weight markers (~500 ng per band); molecular masses are indicated at left.
For chromatograms from purification of other variants, see Appendix A. Briefly, the
purification of NE was the first to be performed on a new chromatography system, so the
protocol differed slightly to all of the others. This can be seen in Figure A.1 where samples
of fractions eluted between 170 mL and 570 mL were analysed by SDS-PAGE for the
presence of DnaK. The peak in absorbance at around 60 mL in Figure A.3 was due to an
error that meant that a small volume of elution buffer was pumped onto the column during a
wash step. As can be seen by the very small peak in Figure A.5 very little protein was left
after this mistake.
During purification of the NR variant, initial ATP-agarose chromatography showed little
to no binding of DnaK to the column. The flowthrough was collected, re-dialysed, and the
chromatography repeated with the same result. The column was opened and found to have
an extremely strong odor. The resin was replaced and the column re-poured. This seems to
have increased yield in subsequent purifications, but some NR was lost.
KE and KR showed the best yields.
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All of the Hsc70 variants showed much lower yields than the DnaK variants, as
expected from the lower levels of expression (Figure 3.1). Unexpectedly, all of them also
eluted from the DEAE column at around 19 mS.cm-1, rather than the expected 25 mS.cm-1.
There was a considerable variation in oligomeric states of the samples after size
exclusion. 3T, NE, KE and KR were all predominantly monomeric, while 2T, 2Q, 3Q and
NR were not. Hsp70s are known to dimerise in the ADP bound state. Therefore, ATP is
added to the samples prior to size exclusion chromatography. However, the absence of
NEFs may mean that the samples were still mainly ADP bound. The alternative, that this
represents the presence of aggregates, seems unlikely as no high molecular weight
aggregates show up in Figure 3.8. Another possibility is that the presence of exposed
cysteine residues lead to the formation of intermolecular disulfide bonds. Addition of
reductant to the gel filtration buffer in future will be used to test this.
3.1.7 Confirmation of Variants by Mass Spectroscopy
Results from Quadropole/Orbitrap showed that all of the correct mutations were present in
each variant with no unexpected mutations. The high molecular weight band E (see
Figure C.1) from the 3Q sample also contained Hsc70 variant 3Q, indicating that this was
made up of aggregates that were resistant to SDS and βME. Band F contained the Q520C
mutation, but not the E318C. This may have been from contamination from 2Q. However,
since 2Q was purified after 3Q any contamination was likely to have occured during the
handling of this sample. (See Appendix C for sequences of peptides detected by MS.)
3.2 Fluorescent labelling
The Alexa Fluor® dyes used bind to proteins via a thiol-maleamide conjugation. In order
for this reaction to take place, the thiol group of the target cysteine residue must be in a
reduced state, so TCEP was added to the samples. However, TCEP would have also
competed with the thiols to react with the maleimide moieties. To avoid this, while still
keeping the thiols reduced, samples were incubated with excess TCEP for 30 min, then the
TCEP was removed by desalting.
After desalting into argon-purged buffer the concentration of each variant was
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determined by taking the average of three 280 nm absorbance readings with a Nanodrop
spectrophotometer. These concentrations were then used to calculate the amount of each
protein stock required to label an equal amount of each variant. All variants were then
labelled at the same time, under the same conditions.
With two cysteines available to react on each protein molecule, adding a stoichiometric
amount of AF488 followed by excess AF594 should have resulted in protein molecules
labelled with 2 AF488 moieties, 2 AF594 moieties, or 1 each of AF488 and AF594, in
approximately a 1:1:2 ratio.
3.2.1 Labelling reaction optimisation
The initial protocol used was developed by a previous member of the lab, David Rogowski.
Briefly it involved desalting the protein into FL buffer, adding 10 × excess TCEP, then
bubbling argon through the sample to purge it of oxygen before sealing it in an air-tight
tube. Dyes were then added by injection through a septum in the cap of the tube.
While investigating why a labelling experiment had failed, another member of the lab
noted that their SDS-PAGE samples showed signs of degradation. To try to determine the
cause, samples of DnaK were left overnight at either 4 °C or room temperature. Fresh
samples were labelled using the then standard protocol, or with one of the following
alterations: no dye or DMSO added, no argon bubbled through the sample, no TCEP, or
DMSO to the same volume as the dye in the standard protocol. All 7 samples were then
analysed by SDS-PAGE. The gel was imaged for fluorescence on a Fuji-image LAS-3000
before being stained (Figure 3.9). This experiment showed that the degradation of samples
reported by others was not the result of bubbling argon through the sample, nor the effect of
any of the other components of the reaction, but merely the result of the protein being
degraded over time. The fluorescent image showed that sparging the sample with argon
increased the amount of dye conjugated, but that this increase was far less than that
obtained by not adding reductant. This implied that the TCEP was competing with the
protein to react with the dye.
To avoid this competition by the reductant, it was decided to add the TCEP prior to the
desalting step, thereby facilitating its removal from the sample prior to labelling. In order to
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Figure 3.9: SDS-PAGE gel of initial Alexafluor labelling optimisation. Each lane loaded with
3.2 µL of sample. Upper image stained with Coomassie Blue stain. Lower image, the same gel
imaged for fluorescence. Marker lane, molecular weight marker; 4 Degrees, Sample incubated at
4 °C for 16 h; Room temp, sample incubated at 20 °C for 16 h; Standard labeling, sample labelled
using standard labelling protocol; No dye/no DMSO, as previous lane except MQ added in place of
dye; No bubbling, as Standard labeling lane except argon tube held above surface of sample instead
of bubbling argon through sample; No TCEP, as Standard labeing lane except MQ added in place of
TCEP; No dye, as Standard labeling lane except straight DMSO added in place of dye.
prevent the cysteine residues being oxidised again after desalting and prior to dye
conjugation, the fluorescent labelling (FL) buffer used for desalting was thoroughly
degassed and sparged with argon.
FL buffer was degassed under partial vacuum then had zero-grade argon bubbled
through it at 3 L min-1 for at least 1 h. Samples to be labelled were thawed on ice and
centrifuged at 13000 rcf for 5 min. One milligram of protein was aliquoted into a
microcentrifuge tube. To reduce the thiols of the target cysteine residues for conjugation
with the maleamide of the AF dye, 10 µL 0.5 M TCEP at pH 7 was added and the volume
brought up to 500 µL with argon-purged FL buffer. Samples were incubated at RT for
30 min. TCEP was then removed by desalting with Sephadex G-25 DNA grade NAP-5
columns equilibrated with argon-purged FL buffer into an argon filled centrifuge tube in an
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argon filled 10 L container. A small aliquot was then tested via spectrophotometry on a
Nanodrop spectrophotometer to determine the concentration. Samples were then transferred
to 4 mL amber HPLC auto-sampler tubes containing magnetic stir bars. The sample
volumes were increased to 2.5 mL, and the tubes were filled with argon and sealed with
screw top septum caps. Samples were placed on a stir-plate in a darkroom under a
foil-covered beaker to prevent photo-bleaching.
Stoichiometric amounts of AF488 were added by injection through the septa with a
Hamilton syringe. Samples were incubated for 30 min, then AF594 was added at 10 ×
molar excess. For single label controls, DMSO was added in place of the other dye.
Excess unreacted dye was removed by desalting with a HiPrep 26/10 desalting column
equilibrated and run with FL buffer at a flowrate of 6 mL per min. One millilitre fractions
were collected and pooled. Pooled samples were dialysed overnight in FL dialysis buffer
containing a charcoal slug at 4 °C to remove bound nucleotide. Samples were recovered
and MgCl2 added to a final concentration of 10 mM. Samples labelled in this way showed
no change in FRET signal upon addition of ATP or ADP, but stilled showed conformational
change when analysed by limited proteolysis. In order to investigate the anomalous data
produced by the ensemble FRET compared to limited proteolysis (see 3.3 and 3.5),
remaining samples were thawed and scanned for absorbance over the range from 200 to
700 nm using an Agilent Technologies Cary series UV-Vis spectrophotometer. Spectra were
corrected for baseline and dye to protein ratios calculated from A280, A495 and A590
(Appendix table B.1).
The values obtained indicated that almost none of the dye added was being conjugated
to the protein. A similar problem has been shown in the literature (Shafer et al. (2000)). In
that paper, the authors reported that not only was the TCEP competing with their protein in
their conjugation reaction, but also this ~250 Da reagent was not removed from their
~65,000 Da bovine serum albumin (BSA) sample by desalting through G25 resin.
To test if the same situation was occuring here, samples of TCEP and DnaK KE were
desalted separately through NAP-5 columns, and the eluate collected drop-wise. Each drop
was then tested for reductant by comparing its ability to reduce oxidised glutathione to that
of known concentrations of TCEP. Each drop of the DnaK sample was tested for protein
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Figure 3.10: Graph of elution of protein and TCEP vs. total eluate from a NAP-5 desalting
column. Protein concentration in µg.mL-1 shown in blue. Concentration of TCEP in mM shown as
solid red line. Concentration of DTT shown as dotted red line.
concentration via absorbance at 280 nm. The results were plotted in Figure 3.10.
A similar test of the elution of DTT showed small amounts of DTT in the final drop of
the elution (as shown by the dashed red line in Figure 3.10), but none earlier. Consequently,
DTT was used as the reductant for all subsequent labelling reactions. Initial experiments
still showed poor dye to protein ratios. To determine whether this was due to loss of sample
during desalting, aliquots of the desalted sample were taken and A280 measurements taken
using a Nanodrop spectrophotometer. However, these readings were inconsistent and
unreliable, apparently due to the argon saturated buffer forming bubbles in the detector.
To avoid the possibility of small amounts of DTT that may have come through the
desalting column, all samples were subsequently eluted in 900 µL of buffer. To compute
stoichiometries, samples were assumed to be 90 % of the initial amount. To determine the
amount of dye bound to each variant, samples were scanned for absorbance between 450
and 650 nm. This range covers the absorbance maxima of both dyes. From the absorbance
at 594 nm the amount of AF594 can be calculated by dividing by its extinction coefficient.
AF488 has an absorbance maxima at 495 nm; however, AF594 also absorbs at this
wavelength. To determine the contribution from AF594 to the absorbance at 495 nm, the
measurement of the absorbance at this wavelength by the 594only sample was used. Since
this absorbance could only be due to the AF594, the ratio of absorbances at 495 nm and
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594 nm of the 594only sample could be used to calculate the absorbance by AF594 in the
other samples as shown in Equation 3.1.







Where Dx equals the absorbance at 495 nm by the AF488 in sample x. Dobs equals the
observed absorbance at 495 nm for sample x. Aobs equals the observed absorbance at
594 nm for sample x. D594 equals the absorbance at 495 nm by isolated AF594. A594 equals
the absorbance at 594 nm by isolated AF594. The amount of AF488 attached to each
sample could now be calculated by dividing the derived absorbance by the extinction
coefficient. To calculate final protein concentration, absorbance at 280 nm was recorded
from the same samples as used for the absorbance of the dyes. Because both of the
Alexafluor dyes absorb at 280 nm, their contribution to the absorbance had to be subtracted
from the signal before calculating the protein concentration. This was done using
Equation 3.2.
Px = Pxobs − ((0.56×A594)+(0.11×Dx)) (3.2)
Where Px is the absorbance at 280 nm by the protein in the sample measured. Pxobs is the
absorbance at 280 nm observed. A594 is the absorbance at 594 nm of the sample. Dx is the
absorbance at 495 nm of the sample after correction for absorbance by AF594 (see above).
The concentrations of protein and dyes in each sample is shown in Table 3.1.
Table 3.1: Protein and dye concentrations
Variant Proteina AF488a AF594a Labelling efficiencyb
NE 124 124 21 58
NR 152 67 227 97
KE 160 221 37 81
KR 281 74 125 35
2T 16 9 7 50
2Q 74 67 14 55
3T 315 37 296 53
3Q 255 61 23 16
a Concentration in nM
b Percentage of cysteine residues labelled
CHAPTER 3. RESULTS 47
3.3 Ensemble FRET
The positions of the cysteines introduced in the variants for this study were chosen such that
the Hsc70 variants would be analogous to the DnaK variants. For example, the Hsc70
E255C was chosen to be analogous to the DnaK N254C position, and the Hsc70 Q520C
was chosen to be equivalent to the DnaK R517C, therefore, 2Q should be analogous to NR
(Figure 2.1). Ensemble FRET was carried out to allow pair-wise comparisons of the change
in conformation of DnaK/Hsc70 upon the addition of nucleotide. If DnaK and Hsc70
behave in the same way, the change in FRET efficiency within each pair of variants should
be similar when nucleotide binds. To study this, nucleotide was removed by chelating the
co-ordinating magnesium ion, then the magnesium was added back to the protein so that it
was capable of re-binding nucleotide.
Scanning fluorescence spectra were then taken of each protein after the addition of ATP,
ADP or buffer lacking nucleotide (Figures 3.11 and 3.12). Scans of buffer with the
appropriate nucleotide were subtracted to account for any background fluorescence. To
account for direct excitation of the AF594, a sample with only AF594 conjugated to it was
also scanned, and the resulting spectrum subtracted as described in Section 2.2.8. Spectra of
all samples excited at 590 nm were also taken. Since the donor fluorophore does not absorb
or emit at these wavelengths, the fluorescence at 617 nm comes only from the acceptor
(Figure 3.13). This shows that the lack of FRET response from 3Q in Figure 3.12 was due
to a complete lack of acceptor fluorophore.
In FRET an increase in signal intensity from one dye results in a corresponding
decrease in intensity of the other, and visa versa. This means that the changes in signal
strength shown for NE, for example, are not due solely to FRET, while those for KE are
most likely due to FRET.
NR showed the highest labelling efficiency, but showed a relatively weak FRET
response. 2T and 2Q both showed very weak signal and no FRET response. 2T, once
labelled, appeared to be almost insoluble under these conditions. 3Q labelled very poorly,
with the lowest labelling efficiency and gave no FRET signal. KR, the DnaK equivilent of
3Q, also labelled poorly, but showed a possible FRET response in the presence of ATP.
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Figure 3.13: Emission spectra from excitation at 590 nm normalised for protein concentration.
Samples were excited at 590 nm and resulting spectra divided by protein concentration.
3T showed a large FRET response in the presence of ATP despite having a labelling
efficiency of just over 50% . Its DnaK equivalent, KE, had a high labelling efficiency, but
that was mostly due to greater than a stoichiometric amount of donor dye and a low level of
acceptor. Interestingly, it showed a large FRET response in the presence of both ATP and
ADP.
3.4 Single molecule FRET
While ensemble FRET looks at the average conformation of the target molecules in a
solution, single molecule FRET allows the observation of the discreet changes in
conformation of a single molecule. This allows the detection of transient states that would
be missed during ensemble FRET measurements.
In this study single molecule FRET was attempted using TIRF microscopy. This
involves the excitation of the donor fluorophore by the evanescent wave created by a laser
of the appropriate wavelength striking the underside of a cover-slip, to which the molecule
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Table 3.2: Changes in fluorescence and increases in FRET efficiency relative to no nucleotide
bound state
Variant
No nucleotide ATP ADP
488a 594b ∆488c ∆594d ∆488c ∆594d
NE 229 8 6 5 8 5
NR 233 20 -4 3 -7 5
2T 29 1 -1 0 -2 0
2Q 114 5 -3 0 -1 1
KE 410 25 -81 20 -8 4
KR 190 27 -5 3 0 0
3T 189 35 -65 16 6 4
3Q 310 21 -5 0 -9 0
a Fluorescence emission intensity at 519 nm in arbitrary fluorescence
units.
b Fluorescence emission intensity at 617 nm in arbitrary fluorescence
units.
c Change in fluorescence emission intensity at 519 nm relative to that
of no nucleotide state in arbitrary fluorescence units.
d Change in fluorescence emission intensity at 617 nm relative to that
of no nucleotide state in arbitrary fluorescence units.
is attached, at such an angle as to cause the laser to be reflected back without passing
through the cover-slip. This avoids background signal caused by the direct detection of the
excitation laser, thus significantly increasing the signal to noise ratio. However, due to the
extremely short penetration of the evanescent wave, the target molecule must be very close
to the surface of the cover-slip. To achieve this, the Hsc70/DnaK was attached to the
cover-slip via a PEG-biotin spacer. In order to ensure that protein molecules were far
enough apart to differentiate individual signals, the PEG-biotin was mixed with
non-biotinylated PEG in a 1 in 40 ratio.
Typical frames from the images recorded are shown in Figure 3.14. The frame in the top
left shows many fluorescent particles in the left-hand donor channel, but almost all have
burnt out by frame 1000, in the bottom right, less than 30 s later. This is due to
photobleaching. In samples without freshly made Trolox added, this photobleaching was
usually complete within 200 frames. Unfortunately, the PEG appeared to fluoresce slightly,
this was particularly evident as diffuse signal in the acceptor channel (Yellow circle in
Figure 3.14). The extremely short focal length also meant that the very minor heating
resulting from the laser required constant refocusing throughout the experiment. On top of
this, the PEG allowed the protein to move slightly during the experiment. This meant that
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when the signal decreased, whether due to FRET transfer or a momentary loss of focus, the
Matlab software used to track it sometimes lost track of the molecule and began tracking
nearby dust instead (Green trace in third panel from the top Figure 3.15).
Figure 3.14: Representative images from TIRF microscope. From top left to bottom right, im-
ages 40, 41, 100 and 1000 from one TIRF experiment. Each image shows fluorescence at 525 nm
on the left and 600 - 650 nm on the right. Large yellow circle indicates background fluorescence
from PEG. Red and green circles show potential FRET signals. The darker area toward the top of
each frame is an artifact of the microscope setup. The black bar down the middle of each frame is an
artifact caused by the beam-splitter.
Attempts to analyse the resulting data using the MATLAB scripts TwoTone and
TwoQuick2Plot produced large numbers of traces which followed the fluorescence of dust
particles and PEG molecules (Figure 3.15). The upper trace shows signal only in one
channel, in this case the acceptor channel. Due to the relatively high intensity of the signal,
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it is unlikely that this was a result of direct excitation of the acceptor dye, and was more
likely a dust particle. The only way to differentiate these from actual signal was found to be
to manually examine each trace, and choose those which appeared to show real FRET
signals. The bottom trace in Figure 3.15 between frames 500 and 800 shows what FRET
signal should look like, with the two signals being anti-correlated, i.e., one increases in
intensity whenever the other decreases. Many traces, such as the second from the top in
Figure 3.15, showed signal in both channels, but lacked this anti-correlation, and were
therefore disregarded.
Figure 3.15: Typical traces from MATLAB analysis of smFRET TIRF images. Traces show
changes in intensity per 100 ms frame. Y-axis intensity in arbitrary unit. Green trace shows signal
from the donor channel. Blue trace shows signal from the acceptor channel.
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While a very small number of traces were found which appeared to show transitions
between different FRET states, the lack of suitable traces, and the difficulty establishing an
objective selection procedure, made this method of analysis too subjective. As a result, this
line of investigation was abandoned until a new method of analysis becomes available.
3.5 Limited proteolysis
To determine whether the ability of the sample to undergo conformational change upon
binding nucleotide had been compromised, limited proteolysis was performed. In this
technique, sample with the appropriate nucleotide bound was incubated with fungal
proteinase K for a limited period of time, then precipitated by TCA/acetone precipitation.
The protein was then resuspended in SDS-PAGE sample loading buffer and analysed by
SDS-PAGE.
Due to the limited amount of time between the addition of the proteinase K and the
precipitation step, the proteinase is only able to partially digest the sample. Whatever the
conformation of the Hsc70 or DnaK, the ends are cleaved leading to a band of around
60 kDa on the gels. This is refered to as truncated full length, since it still contains both
domains. Hsc70 shows two bands here, indicating an alternate or additional cleavage site.
If the linker region of the Hsc70 or DnaK is exposed, this is cleaved, leading to separate
NBD and SBD bands at about 44 and 23 kDa, respectively.
The ratios of cleaved to uncleaved protein under each condition could then be compared
to see if the conformation of the protein was nucleotide dependent. Since the linker region
of the DnaK/Hsc70 was only exposed during the ATP bound state, it was expected that
there would be less cleaved protein in the ADP bound and no nucleotide states than in the
ATP bound state (Figures 3.16, 3.17, 3.18, 3.19, 3.20). Note that in Figure 3.16, the ADP
bound and no nucleotide states of Hsc70 look very similar, while the ADP bound state of
DnaK appears intermediate between the ATP bound and no nucleotide states. There is no
indication that any of the variants in this study show different patterns of cleavage to these,
suggesting that all undergo conformational change in response to nucleotide, even after the
addition of Alexa Fluor® dyes.
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Figure 3.16: SDS-PAGE showing the effects of differing nucleotide states on the results of
limited proteolysis of Hsc70 ∆2C and DnaK C15S by fungal proteinase K. Sizes of predicted
bands of interest indicated by coloured arrows at right. Red arrow = full length protein, green arrow
= truncated full length (see text), magenta arrow = NBD, blue arrow = proteinase K, green arrow =
SBD. Marker lane as in Figure 3.1.
Figure 3.17: SDS-PAGE showing the effects of differing nucleotide states on the results of
limited proteolysis of Hsc70 2Q and DnaK NR by fungal proteinase K. Sizes of predicted bands
of interest indicated by coloured arrows at right. Red arrow = full length protein, green arrow =
truncated full length (see text), magenta arrow = NBD, blue arrow = proteinase K, green arrow =
SBD. Marker lane as in Figure 3.1.
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Figure 3.18: SDS-PAGE showing the effects of differing nucleotide states on the results of
limited proteolysis of Hsc70 2T and DnaK NE by fungal proteinase K. Sizes of predicted bands
of interest indicated by coloured arrows at right. Red arrow = full length protein, green arrow =
truncated full length (see text), magenta arrow = NBD, blue arrow = proteinase K, green arrow =
SBD. Marker lane as in Figure 3.1.
Figure 3.19: SDS-PAGE showing the effects of differing nucleotide states on the results of
limited proteolysis of Hsc70 3Q and DnaK KR by fungal proteinase K. Sizes of predicted bands
of interest indicated by coloured arrows at right. Red arrow = full length protein, green arrow =
truncated full length (see text), magenta arrow = NBD, blue arrow = proteinase K, green arrow =
SBD. Marker lane as in Figure 3.1.
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Figure 3.20: SDS-PAGE showing the effects of differing nucleotide states on the results of
limited proteolysis of Hsc70 3T and DnaK KE by fungal proteinase K. Sizes of predicted bands
of interest indicated by coloured arrows at right. Red arrow = full length protein, green arrow =
truncated full length (see text), magenta arrow = NBD, blue arrow = proteinase K, green arrow =
SBD. Marker lane as in Figure 3.1.
Chapter 4
Discussion
4.1 Expression and purification
In this work, eight Hsp70 variants were expressed and purified. Solubility, yield and activity
of these variants were compared. These variant proteins were then labelled with fluorescent
dyes to investigate conformational change upon nucleotide binding.
Overall, expression levels of Hsc70 were lower than those of DnaK. The two most
apparent reasons for this were the different plasmids used for each, and the cells used for
expression. The plasmid used to express the DnaK variants used a tac promotor and
contained a lacIq system to control the Tac promotor used to express the DnaK gene. This
allows high levels of expression in a range of cells including the DE3 lysogen. The plasmid
currently used for expression of Hsc70 used a T7 promoter, meaning that it can only be
expressed in cells capable of producing T7 RNA polymerase.
In order to avoid contamination with native DnaK, all recombinant proteins were
expressed in DnaK knockout cells. These BB1553 cells grow slower than other E. coli K12
cells (Bukau and Walker, 1989). A previous member of the Wilbanks lab added the DE3
lysogen to these cells to produce BB1553(DE3) cells (Renshaw, 2015). They produce a
lower yield than that of DnaK expressed in BB1553.
One way to solve both of these issues would be to clone the Hsc70 sequence into the
plasmid used for DnaK expression under control of a tac promotor. This would allow
expression in the same BB1553 cells currently used for expressing DnaK, without the need
to use the less viable BB1553(DE3) cells currently used. This approach has to date been
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complicated by a lack of sequence data for the pRBH plasmid that encodes the DnaK
sequence used. The sequencing of this plasmid is ongoing within the Wilbanks lab.
Interestingly, the Hsc70 variants eluted from the DEAE column earlier than the DnaK
variants. This had not been expected. This might have the potential to allow separation of
endogenous DnaK from recombinant Hsc70, and thus allow expression in a more robust E.
coli strain, such as BL21(DE3). However, DnaK is known to bind to recominant protein
(Hellebust et al., 1990), so may end up co-purifying with the Hsc70.
Another potential approach would be to express the Hsc70 in cells which are still
capable of expressing DnaK, such as BL21(DE3), and altering the purification protocol to
separate the two Hsp70s. This has been done via iso-electric focusing chromatography
using a Mono-P column (Braun et al., 1996).
A third approach would be to utilise a split-intein approach to express the NBD and
SBDs seperately, each fused to split-intein fragments. In this way each domain could be
labeled independently, then fused back together. This method also has the advantage of
allowing affinity tags to be attached to the split intein fragment for ease of purification,
which would then not be present in the final fused protein product.
4.2 Labelling
A great deal of time and reagents were expended establishing a useful labelling protocol. In
retrospect, some of the lessons learned were already documented in the literature, but are
not well known. In particular, advice from the manufacturers of reagents was not always
accurate. While the manufacturer claimed that TCEP was better for reducing maleimide
moieties than DTT, my experiments showed that TCEP was worse than using no reductant
at all (Figure 3.9).
Upon completion of this work the labelling protocol was still not fully optimised with
most of the samples still only being labelled at about 50% efficiency. This was in part due
to the fact that exact measurements of protein concentration at a key step in the proceedure
were not yet obtainable. Since the absolute amounts of protein used were very small, in the
hundreds of nanomoles, any error in the concentration measurement had a very large effect.
This obstacle may soon be overcome by improvements in microlitre volume
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spectrophotometers.
4.3 FRET and limited proteolysis
The labeling was sufficient to determine that some of the variants tested were able to
produce a FRET signal, and to undergo nucleotide dependent conformational change. For
future study of Hsc70, the E318C/T427C variant showed greatest promise.
While none of the Hsc70 variants showed labelling efficiency much over 50%, not all of
them failed in the same way (Table 3.1).
The two Q520C variants, 2Q and 3Q, bound very little acceptor dye when the initial
donor dye was added at apparently stoichiometric amounts. When less of the donor was
added, acceptor could bind, but the variants showed no sign of a change in FRET signal in
response to nucleotide binding. This is despite limited proteolysis data showing that they
were still undergoing conformational shifts (Figure 3.17). A possible explanation for this is
that the Q520 position is not competent to react with the maleimide moiety of the dye
molecule. This may be because this position is not actually solvent exposed, or the local
environment makes it unreactive. We can rule out the third possibility, that the cysteine
residue is not present, as its presence was confirmed by mass spectrometry (Appendix C).
Another possibility is that the conformational shift does not change the FRET efficiency.
Labelling of the E255C/T427C variant appears to decrease the solubility, as very little
sample remained in solution after HiPrep desalting, as evidenced by the very low signal
strength in Figure 3.11. Limited proteolysis of this variant showed very little due to this loss
of sample (Figure 3.18).
A previous member of the Wilbanks lab had shown that without 10 % v/v glycerol in
the buffer, the addition of hydrophobic dyes to DnaK made it more vunerable to
precipitation, and that the protein showed a reduced change in FRET signal upon the
addition of ATP (Rogawski, 2010). In cases where samples were snap frozen after labelling,
all variants showed a tendency to precipitate while thawing. This was despite 10% v/v
glycerol being present in all buffers after labelling.
Of the DnaK variants, both the K321C/E430C and K321C/R517C variants showed a
change in FRET signal upon ATP binding. The K321C/E430C showed a greater change in
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signal than the K321C/R517C variant which was produced for this work, but not so great as
that of the Hsc70 E318C/T427C. The limited proteolysis results for both of these samples
were very faint, but indicated a pattern similar to that of DnaK C15S (Figure 3.16). This
confirms that these variants are still capable of undergoing the same nucleotide dependent
conformational shift.
The Hsc70 E318C/T427C was designed to be equivalent to the DnaK K321C/E430C.
While both of these variants showed a sizable change in FRET in response to ATP, only the
DnaK variant showed a change in response to ADP. This indicates either that the 5 residue
difference in the positions of the dye has an effect on the FRET efficiency, or that the two
molecules undergo different conformational shifts. The variation in the thickness of the
proteinase K band in the limited proteolysis results for this pair shown in Figure 3.20
indicates uneven loads in each lane. This makes interpretation of this figure difficult.
However, the ADP and no nucleotide lanes of the E318C/T427C sample look similar to one
another, while those of the K321C/E430C do not. These differences are difficult to compare
due to the differences in the dye to protein ratios of the samples, but indicate that the DnaK
and Hsc70 conformations are not identical when bound to ADP. This matches the difference
seen by FRET. This shows why it is important to study Hsc70, rather than relying on DnaK
as a model for eukaryotic systems.
Also of interest are the data for the N254C/R517C variant. Here there was very little
change in the FRET signal, but importantly the ADP bound state in this variant appears to
be more similar to the ATP bound state than to the no nucleotide bound. The limited
proteolysis result in Figure 3.17 also shows an ADP pattern different to both the ATP and
no nucleotide patterns. This is intriguing, as many models of the ADP bound state are based
on samples which have no nucleotide bound. This differing pattern between Hsc70 and
DnaK in the presence of ADP is also shown clearly in Figure 3.16. From this we can see
that the Hsc70 molecule spends more time sampling an open conformation in an ADP
bound state than DnaK does. This difference has implications for using DnaK as a model
for Hsc70 activity.
It is important to note that one of the aims of this study was to look for appropriate
variants to use in future single molecule FRET studies. While in ensemble FRET noise
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from poorly labelled sample can make interpreting signal difficult, this is not a problem in
smFRET.
In conclusion
In this study several variants of Hsc70 were created and tested for suitability for use in
future smFRET studies of Hsc70. Of those created, the E318C/T427C variant proved to be
the best variant for future work, as it can be labelled, and once labelled, it can provide a
strong enough signal to be informative.
This study also showed that the ADP bound state of Hsp70s is not the same as the no
nucleotide state, and that the conformations of Hsc70 and DnaK were different. The limited
proteolysis data produced showed that the ADP bound state of DnaK was less susceptible to
proteolytic cleavage than the no nucleotide state, while the ADP bound and no nucleotide
states of Hsc70 were much more similar. This finding is particularly important to focus
future studies on the medically relevant eukaryotic Hsp70s, and comparisons between the
physiologically relevant ADP and ATP bound states.
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Figure A.1: Chromatograph showing DEAE purification of DnaK variant NE. Blue trace
indicates absorbance at 280 nm. Red trace indicates conductivity. Fractions analysed by SDS-PAGE
are indicated in green. Fractions pooled for further purification are in dark green.
Figure A.2: SDS-PAGE gel analysis of DEAE chromatography of DnaK variant NE. Marker
lane contains molecular weight markers (~500 ng per band); molecular masses are indicated at left.
Lane 2 contains 0.01% of the clarified cell lysate which was loaded onto the DEAE column. Other
lanes contain 0.05% of the fractions indicated by the numbers at the top. Green numbers indicate
fractions pooled for futher purification.
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Figure A.3: Chromatograph showing ATP-agarose purification of DnaK variant NE. Blue trace
indicates absorbance at 280 nm. Shaded bars show buffer steps. Fractions analysed by SDS-PAGE
are indicated in green. Fractions pooled for further purification are in dark green.
Figure A.4: SDS-PAGE gel analysis of ATP-agarose chromatography of DnaK variant NE.
Marker lanes contain molecular weight markers (~500 ng per band); molecular masses are indicated
at left. Lane 2 contains 0.005% of the sample which was loaded onto the ATP-agarose column. Lane
3 contains 0.4% of the 60th mL of flow-through. Other lanes contain 0.4% of the fractions indicated
by the numbers at the top.
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Figure A.5: Chromatograph showing gel filtration purification of DnaK variant NE. Blue trace
indicates absorbance at 280 nm. Fractions analysed by SDS-PAGE and pooled for further analysis
are indicated in dark green.
Figure A.6: Chromatograph showing DEAE purification of DnaK variant NR. Blue trace
indicates absorbance at 280 nm. Red trace indicates conductivity. Fractions analysed by SDS-PAGE
are indicated in green. Fractions pooled for further purification are in dark green.
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Figure A.7: Chromatograph showing ATP-agarose purification of DnaK variant NR. Blue trace
indicates absorbance at 280 nm. Shaded bars show buffer steps. Fractions analysed by SDS-PAGE
are indicated in green. Fractions pooled for further purification are in dark green.
Figure A.8: SDS-PAGE gel analysis of ATP-agarose chromatography of DnaK variant NR.
Marker lanes contain molecular weight markers (~500 ng per band); molecular masses are indicated
at left. Lane 2 contains 0.005% of the sample which was loaded onto the ATP-agarose column. Lane
3 contains 0.4% of the 60th mL of flow-through. Other lanes contain 0.4% of the fractions indicated
by the numbers at the top.
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Figure A.9: Chromatograph showing gel filtration purification of DnaK variant NR. Blue trace
indicates absorbance at 280 nm. Fractions analysed by SDS-PAGE and pooled for further analysis
are indicated in dark green.
Figure A.10: SDS-PAGE gel analysis of gel filtration chromatography of DnaK variant NR.
Marker lanes contain molecular weight markers (~500 ng per band); molecular masses are indicated
at left. Experimental lanes contain 0.16% of the fractions indicated by the numbers at the top.
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Figure A.11: Chromatograph showing DEAE purification of DnaK variant KR. Blue trace
indicates absorbance at 280 nm. Red trace indicates conductivity. Fractions analysed by SDS-PAGE
are indicated in green. Fractions pooled for further purification are in dark green.
Figure A.12: SDS-PAGE gel analysis of DEAE chromatography of DnaK variant KR. Marker
lane contains molecular weight markers (~500 ng per band); molecular masses are indicated at left.
Lane 2 contains 0.01% of the clarified cell lysate which was loaded onto the DEAE column. Other
lanes contain 0.05% of the fractions indicated by the numbers at the top. Green numbers indicate
fractions pooled for futher purification.
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Figure A.13: Chromatograph showing ATP-agarose purification of DnaK variant KR. Blue
trace indicates absorbance at 280 nm. Shaded bars show buffer steps. Fractions analysed by SDS-
PAGE are indicated in green. Fractions pooled for further purification are in dark green.
Figure A.14: SDS-PAGE gel analysis of ATP-agarose chromatography of DnaK variant KR.
Marker lanes contain molecular weight markers (~500 ng per band); molecular masses are indicated
at left. Lane 2 contains 0.005% of the sample which was loaded onto the ATP-agarose column. Lane
3 contains 0.4% of the 60th mL of flow-through. Other lanes contain 0.4% of the fractions indicated
by the numbers at the top.
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Figure A.15: Chromatograph showing gel filtration purification of DnaK variant KR. Blue
trace indicates absorbance at 280 nm. Fractions analysed by SDS-PAGE and pooled for further anal-
ysis are indicated in dark green.
Figure A.16: Chromatograph showing DEAE purification of Hsc70 variant 2T. Blue trace
indicates absorbance at 280 nm. Red trace indicates conductivity. Fractions analysed by SDS-PAGE
are indicated in green. Fractions pooled for further purification are in dark green.
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Figure A.17: SDS-PAGE gel analysis of DEAE chromatography of Hsc70 variant 2T. Marker
lane contains molecular weight markers (~500 ng per band); molecular masses are indicated at left.
Lane 2 contains 0.01% of the clarified cell lysate which was loaded onto the DEAE column. Other
lanes contain 0.05% of the fractions indicated by the numbers at the top. Green numbers indicate
fractions pooled for futher purification.
Figure A.18: Chromatograph showing ATP-agarose purification of Hsc70 variant 2T. Blue
trace indicates absorbance at 280 nm. Shaded bars show buffer steps. Fractions analysed by SDS-
PAGE are indicated in green. Fractions pooled for further purification are in dark green.
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Figure A.19: SDS-PAGE gel analysis of ATP-agarose chromatography of Hsc70 variant 2T.
Marker lanes contain molecular weight markers (~500 ng per band); molecular masses are indicated
at left. Lane 2 contains 0.005% of the sample which was loaded onto the ATP-agarose column. Lane
3 contains 0.4% of the 60th mL of flow-through. Other lanes contain 0.4% of the fractions indicated
by the numbers at the top.
Figure A.20: Chromatograph showing gel filtration purification of Hsc70 variant 2T. Blue trace
indicates absorbance at 280 nm. Fractions analysed by SDS-PAGE and pooled for further analysis
are indicated in dark green.
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Figure A.21: Chromatograph showing DEAE purification of Hsc70 variant 2Q. Blue trace
indicates absorbance at 280 nm. Red trace indicates conductivity. Fractions analysed by SDS-PAGE
are indicated in green. Fractions pooled for further purification are in dark green.
Figure A.22: SDS-PAGE gel analysis of DEAE chromatography of Hsc70 variant 2Q. Marker
lane contains molecular weight markers (~500 ng per band); molecular masses are indicated at left.
Lane 2 contains 0.01% of the clarified cell lysate which was loaded onto the DEAE column. Other
lanes contain 0.05% of the fractions indicated by the numbers at the top. Green numbers indicate
fractions pooled for futher purification.
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Figure A.23: Chromatograph showing ATP-agarose purification of Hsc70 variant 2Q. Blue
trace indicates absorbance at 280 nm. Shaded bars show buffer steps. Fractions analysed by SDS-
PAGE are indicated in green. Fractions pooled for further purification are in dark green.
Figure A.24: SDS-PAGE gel analysis of ATP-agarose chromatography of Hsc70 variant 2Q.
Marker lanes contain molecular weight markers (~500 ng per band); molecular masses are indicated
at left. Lane 2 contains 0.005% of the sample which was loaded onto the ATP-agarose column. Lane
3 contains 0.4% of the 60th mL of flow-through. Other lanes contain 0.4% of the fractions indicated
by the numbers at the top.
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Figure A.25: Chromatograph showing gel filtration purification of Hsc70 variant 2Q. Blue
trace indicates absorbance at 280 nm. Fractions analysed by SDS-PAGE and pooled for further anal-
ysis are indicated in dark green.
Figure A.26: Chromatograph showing DEAE purification of Hsc70 variant 3T. Blue trace
indicates absorbance at 280 nm. Red trace indicates conductivity. Fractions analysed by SDS-PAGE
are indicated in green. Fractions pooled for further purification are in dark green.
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Figure A.27: SDS-PAGE gel analysis of DEAE chromatography of Hsc70 variant 3T. Marker
lane contains molecular weight markers (~500 ng per band); molecular masses are indicated at left.
Lane 2 contains 0.01% of the clarified cell lysate which was loaded onto the DEAE column. Other
lanes contain 0.05% of the fractions indicated by the numbers at the top. Green numbers indicate
fractions pooled for futher purification.
Figure A.28: Chromatograph showing ATP-agarose purification of Hsc70 variant 3T. Blue
trace indicates absorbance at 280 nm. Shaded bars show buffer steps. Fractions analysed by SDS-
PAGE are indicated in green. Fractions pooled for further purification are in dark green.
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Figure A.29: SDS-PAGE gel analysis of ATP-agarose chromatography of Hsc70 variant 3T.
Marker lanes contain molecular weight markers (~500 ng per band); molecular masses are indicated
at left. Lane 2 contains 0.005% of the sample which was loaded onto the ATP-agarose column. Lane
3 contains 0.4% of the 60th mL of flow-through. Other lanes contain 0.4% of the fractions indicated
by the numbers at the top.
Figure A.30: Chromatograph showing gel filtration purification of Hsc70 variant 3T. Blue trace
indicates absorbance at 280 nm. Fractions analysed by SDS-PAGE and pooled for further analysis
are indicated in dark green.
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Figure A.31: Chromatograph showing DEAE purification of Hsc70 variant 3Q. Blue trace
indicates absorbance at 280 nm. Red trace indicates conductivity. Fractions analysed by SDS-PAGE
are indicated in green. Fractions pooled for further purification are in dark green.
Figure A.32: Chromatograph showing ATP-agarose purification of Hsc70 variant 3Q. Blue
trace indicates absorbance at 280 nm. Shaded bars show buffer steps. Fractions analysed by SDS-
PAGE are indicated in green. Fractions pooled for further purification are in dark green.
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Figure A.33: Chromatograph showing gel filtration purification of Hsc70 variant 3Q. Blue
trace indicates absorbance at 280 nm. Fractions analysed by SDS-PAGE and pooled for further anal-
ysis are indicated in dark green.
Appendix B
Dye to protein ratios after TCEP
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Figure C.1: SDS-PAGE gel showing sample submitted for MS analysis. Bands sent for analysis
indicated in red. Hsc70 variants in each lane indicated.
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